| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Hester Biosciences Limited (NSE: HESTERBIO)
HESTERBIO Technical Analysis
4
| As on 24th Apr 2024 HESTERBIO SHARE Price closed @ 1684.50 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1593.04 & Strong Buy for SHORT-TERM with Stoploss of 1459.36 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HESTERBIOSHARE Price
| Open | 1666.85 | Change | Price | % |
| High | 1702.45 | 1 Day | 25.90 | 1.56 |
| Low | 1648.05 | 1 Week | 71.55 | 4.44 |
| Close | 1684.50 | 1 Month | 286.55 | 20.50 |
| Volume | 22586 | 1 Year | -109.90 | -6.12 |
| 52 Week High 2822.90 | 52 Week Low 1522.80 | ||||
NSE INDIA Most Active Stocks
| IDEA | 13.10 | -9.03% |
| SAIL | 164.65 | 8.14% |
| YESBANK | 25.45 | -0.78% |
| TATASTEEL | 165.55 | 2.73% |
| IRFC | 149.00 | 0.85% |
| SOUTHBANK | 29.10 | 1.04% |
| MRPL | 248.70 | 10.75% |
| SUZLON | 41.80 | -0.12% |
| BEL | 236.50 | 0.92% |
| RAMASTEEL | 14.00 | 2.56% |
NSE INDIA Top Gainers Stocks
| ROML | 63.05 | 19.98% |
| COMPUSOFT | 35.20 | 19.93% |
| SHRADHA | 78.55 | 19.83% |
| STEELCITY | 102.95 | 19.78% |
| WEIZMANIND | 142.25 | 19.59% |
| TEMBO | 240.90 | 18.61% |
| CHENNPETRO | 1075.00 | 15.82% |
| YUKEN | 1180.65 | 13.81% |
| ORIENTCEM | 230.50 | 12.85% |
| AEGISCHEM | 604.50 | 12.41% |
NSE INDIA Top Losers Stocks
| HESTERBIO Daily Charts |
HESTERBIO Intraday Charts |
Whats New @ Bazaartrend |
HESTERBIO Free Analysis |
|
|
HESTERBIO Important Levels Intraday
| RESISTANCE | 1789.33 |
| RESISTANCE | 1755.71 |
| RESISTANCE | 1734.93 |
| RESISTANCE | 1714.15 |
| SUPPORT | 1654.85 |
| SUPPORT | 1634.07 |
| SUPPORT | 1613.29 |
| SUPPORT | 1579.67 |
HESTERBIO Target April 2024
| 4th UP Target | 1788.48 |
| 3rd UP Target | 1669.39 |
| 2nd UP Target | 1595.78 |
| 1st UP Target | 1522.17 |
| 1st DOWN Target | 1312.13 |
| 2nd DOWN Target | 1238.52 |
| 3rd DOWN Target | 1164.91 |
| 4th DOWN Target | 1045.82 |
HESTERBIO Weekly Target
| 4th UP Target | 1843.33 |
| 3rd UP Target | 1775.84 |
| 2nd UP Target | 1734.13 |
| 1st UP Target | 1692.41 |
| 1st DOWN Target | 1573.39 |
| 2nd DOWN Target | 1531.67 |
| 3rd DOWN Target | 1489.96 |
| 4th DOWN Target | 1422.47 |
HESTERBIO Target2024
| 4th UP Target | 3135.26 |
| 3rd UP Target | 2597.32 |
| 2nd UP Target | 2264.81 |
| 1st UP Target | 1932.3 |
| 1st DOWN Target | 983.5 |
| 2nd DOWN Target | 650.99 |
| 3rd DOWN Target | 318.48 |
| 4th DOWN Target | -219.46 |
Hester Biosciences Limited ( NSE INDIA Symbol : HESTERBIO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HESTERBIO Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is Below 20 | Over Sold | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 1377.09 | |
| 10 Day Avg Volume | Traded 13.97 % More then 10 Day Average Volume | ||
HESTERBIO Other Details
| Segment | EQ | |
| Market Capital | 21190557696.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
HESTERBIO Address
 |
||
HESTERBIO Latest News
HESTERBIO Business Profile
Hester Biosciences Limited manufactures and trades in veterinary vaccines and health products in India. It operates through Poultry healthcare, Animal Healthcare, and Others segments. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian encephalomyelitis, etc. It also offers vaccines for large animals against Goat Pox, Peste des Petits Ruminants, and Brucellosis diseases, as well as infections, reproductive disorders, theileriosis, and parasitic diseases. In addition, the company provides feed supplements, such as growth tonic, toxin binder, trace minerals, enzyme preparation, and bypass fat; disinfectants for farms and equipment; herbal and nutrition products; and sanitizers. The company also exports its products. Hester Biosciences Limited has a collaboration agreement with Indian Institute of Technology Guwahati to develop vaccine against COVID-19. The company was incorporated in 1987 and is headquartered in Ahmedabad, India. Address: Pushpak, Ahmedabad, India, 380006
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service